{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_1200", "batch_size": 200, "batch_pos": 85, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "No high-potency verb, potent metaphor, superlative, intensifier + harm noun, or critical alert phrase used.", "method": "llm_batch", "batch_id": "batch_2_1200", "batch_size": 200, "batch_pos": 37, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb from the specified list paired with scale/impact.", "method": "llm_batch", "batch_id": "batch_3_1200", "batch_size": 200, "batch_pos": 182, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_1200", "batch_size": 200, "batch_pos": 172, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Reports uncertainty about future manufacturing; not explicitly framed as reassuring.", "method": "llm_batch", "batch_id": "batch_5_1200", "batch_size": 200, "batch_pos": 168, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser ('only', 'just', 'merely', etc.) or explicit scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_1200", "batch_size": 200, "batch_pos": 118, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment contains 'too early to tell' which implies uncertainty, not a Q7 bare negation.", "method": "llm_batch", "batch_id": "batch_7_1200", "batch_size": 200, "batch_pos": 101, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Discusses manufacturing capability: 'how many doses Moderna will be able to manufacture'.", "method": "llm_batch", "batch_id": "batch_8_1200", "batch_size": 200, "batch_pos": 77, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
